TP53 and acute myeloid leukemia: Interestingly, chemotherapy stress not only shapes the clonal evolution of cancer cells but also promotes the expansion of hematopoietic stem/progenitor cells (HSPCs) harboring age-related TP53 heterozygous mutations, predisposing patients to t-AML [22].